UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 797

Sortiert nach

Expertise in rural development: A conceptual and empirical analysis

World development, 2019-04, Vol.116, p.28-37

2019

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetic and Pharmacodynamic Properties of Canakinumab, a Human Anti-Interleukin-1β Monoclonal Antibody

Clinical pharmacokinetics, 2012-06, Vol.51 (6), p.e1-e18

2012

Link zum Volltext

Verfügbarkeit prüfen

Relationship between omalizumab pharmacokinetics, IgE pharmacodynamics and symptoms in patients with severe persistent allergic (IgE‐mediated) asthma

British journal of clinical pharmacology, 2009-07, Vol.68 (1), p.61-76

2009

Link zum Volltext

Verfügbarkeit prüfen

Omalizumab in Asthma: An Update on Recent Developments

The journal of allergy and clinical immunology in practice (Cambridge, MA), 2014-09, Vol.2 (5), p.525-536.e1

2014

Link zum Volltext

Verfügbarkeit prüfen

Revision of omalizumab dosing table for dosing every 4 instead of 2 weeks for specific ranges of bodyweight and baseline IgE

Regulatory toxicology and pharmacology, 2015-02, Vol.71 (1), p.68-77

2015

Link zum Volltext

Verfügbarkeit prüfen

A mechanism‐based binding model for the population pharmacokinetics and pharmacodynamics of omalizumab

British journal of clinical pharmacology, 2007-05, Vol.63 (5), p.548-561

2007

Link zum Volltext

Verfügbarkeit prüfen

England's Rural Futures: A Socio-Geographical Approach to Scenarios Analysis

Regional studies, 2009-12, Vol.43 (10), p.1319-1332

2009

Link zum Volltext

Verfügbarkeit prüfen

Improving priors for human monoclonal antibody linear pharmacokinetic parameters by using half-lives from non-human primates

Journal of pharmacokinetics and pharmacodynamics, 2021-04, Vol.48 (2), p.295-303

2021

Link zum Volltext

Verfügbarkeit prüfen

Asthma symptom re-emergence after omalizumab withdrawal correlates well with increasing IgE and decreasing pharmacokinetic concentrations

Journal of allergy and clinical immunology, 2009, Vol.123 (1), p.107-113.e3

2009

Link zum Volltext

Verfügbarkeit prüfen

Knowledge exchange: a review and research agenda for environmental management

Environmental conservation, 2013-03, Vol.40 (1), p.19-36

2013

Link zum Volltext

Verfügbarkeit prüfen

Two Case Studies on How Study Designs Can Be Made More Informative Using Modeling and Simulation Approaches

Clinical pharmacology and therapeutics, 2017-12, Vol.102 (6), p.908-911

2017

Link zum Volltext

Verfügbarkeit prüfen

Population Pharmacokinetic and Pharmacodynamic Model-Based Comparability Assessment of a Recombinant Human Epoetin Alfa and the Biosimilar HX575

Journal of clinical pharmacology, 2012-11, Vol.52 (11), p.1624-1644

2012

Link zum Volltext

Verfügbarkeit prüfen

Ethnic sensitivity assessment of pharmacokinetics and pharmacodynamics of omalizumab with dosing table expansion

Drug metabolism and pharmacokinetics, 2016-06, Vol.31 (3), p.173-184

2016

Link zum Volltext

Verfügbarkeit prüfen

New Approach To Measure Protein Binding Based on a Parallel Artificial Membrane Assay and Human Serum Albumin

Journal of medicinal chemistry, 2008-04, Vol.51 (7), p.2009-2017

2008

Link zum Volltext

Verfügbarkeit prüfen

On Setting the First Dose in Man: Quantitating Biotherapeutic Drug‐Target Binding through Pharmacokinetic and Pharmacodynamic Models

Basic & clinical pharmacology & toxicology, 2010-03, Vol.106 (3), p.195-209

2010

Link zum Volltext

Verfügbarkeit prüfen

Infectious diseases of animals and plants: an interdisciplinary approach

Philosophical transactions of the Royal Society of London. Series B. Biological sciences, 2011-07, Vol.366 (1573), p.1933

2011

Link zum Volltext

Verfügbarkeit prüfen

European Rural Development under the Common Agricultural Policy's 'Second Pillar': Institutional Conservatism and Innovation

Regional studies, 2007-10, Vol.41 (7), p.873-888

2007

Link zum Volltext

Verfügbarkeit prüfen

From Target Selection to the Minimum Acceptable Biological Effect Level for Human Study: Use of Mechanism-based PK/PD Modeling to Design Safe and Efficacious Biologics

The AAPS journal, 2011-06, Vol.13 (2), p.169-178

2011

Link zum Volltext

Verfügbarkeit prüfen

Physiologically based pharmacokinetic modeling of FTY720 (2-amino-2[2-(-4-octylphenyl)ethyl]propane-1,3-diol hydrochloride) in rats after oral and intravenous doses

Drug metabolism and disposition, 2006-09, Vol.34 (9), p.1480

2006

Link zum Volltext

Verfügbarkeit prüfen

The preservationist paradox: modernism, environmentalism and the politics of spatial division

Transactions - Institute of British Geographers (1965), 2003-09, Vol.28 (3), p.318-332

2003

Link zum Volltext

Verfügbarkeit prüfen

Setting the next agenda? British and French approaches to the second pillar of the Common Agricultural Policy

Journal of rural studies, 2002, Vol.18 (1), p.1-17

2002

Link zum Volltext

Verfügbarkeit prüfen

On the Prediction of the Human Response: A Recycled Mechanistic Pharmacokinetic/Pharmacodynamic Approach

Basic & clinical pharmacology & toxicology, 2005-03, Vol.96 (3), p.182-192

2005

Link zum Volltext

Verfügbarkeit prüfen

Household debt, housing prices and resilience

Economic analysis and policy, 2017-09, Vol.55, p.124-131

Lowe, Philip

2017

Link zum Volltext

Verfügbarkeit prüfen

Enacting Rural Sociology: Or what are the Creativity Claims of the Engaged Sciences?

Sociologia ruralis, 2010-10, Vol.50 (4), p.311-330

Lowe, Philip

2010

Link zum Volltext

Verfügbarkeit prüfen

Multicentre study of the clinical relevance of screening IVF patients for carrier status of the annexin A5 M2 haplotype

Reproductive biomedicine online, 2014-07, Vol.29 (1), p.80-87

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 797

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(663)
Mit Volltextzugriff
(698)

Publikationsform

5 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(403)
Life Sciences & Biomedicine
(334)
Humans
(250)
Male
(111)
Female
(109)
Social Sciences
(106)
Biological And Medical Sciences
(102)
Medical Sciences
(76)
Adult
(66)
Middle Aged
(61)
Animals
(58)
Studies
(54)
Aged
(51)
Environmental Sciences & Ecology
(47)
United Kingdom
(42)
Business & Economics
(39)
Technology
(38)
Physical Sciences
(36)
Europe
(35)
Fundamental And Applied Biological Sciences. Psychology
(35)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Expertise in rural development: A conceptual and empirical analysis

Pharmacokinetic and Pharmacodynamic Properties of Canakinumab, a Human Anti-Interleukin-1β Monoclonal Antibody

Relationship between omalizumab pharmacokinetics, IgE pharmacodynamics and symptoms in patients with severe persistent allergic (IgE‐mediated) asthma

Omalizumab in Asthma: An Update on Recent Developments

Revision of omalizumab dosing table for dosing every 4 instead of 2 weeks for specific ranges of bodyweight and baseline IgE

A mechanism‐based binding model for the population pharmacokinetics and pharmacodynamics of omalizumab

England's Rural Futures: A Socio-Geographical Approach to Scenarios Analysis

Improving priors for human monoclonal antibody linear pharmacokinetic parameters by using half-lives from non-human primates

Asthma symptom re-emergence after omalizumab withdrawal correlates well with increasing IgE and decreasing pharmacokinetic concentrations

Knowledge exchange: a review and research agenda for environmental management

Two Case Studies on How Study Designs Can Be Made More Informative Using Modeling and Simulation Approaches

Population Pharmacokinetic and Pharmacodynamic Model-Based Comparability Assessment of a Recombinant Human Epoetin Alfa and the Biosimilar HX575

Ethnic sensitivity assessment of pharmacokinetics and pharmacodynamics of omalizumab with dosing table expansion

New Approach To Measure Protein Binding Based on a Parallel Artificial Membrane Assay and Human Serum Albumin

On Setting the First Dose in Man: Quantitating Biotherapeutic Drug‐Target Binding through Pharmacokinetic and Pharmacodynamic Models

Infectious diseases of animals and plants: an interdisciplinary approach

European Rural Development under the Common Agricultural Policy's 'Second Pillar': Institutional Conservatism and Innovation

From Target Selection to the Minimum Acceptable Biological Effect Level for Human Study: Use of Mechanism-based PK/PD Modeling to Design Safe and Efficacious Biologics

Physiologically based pharmacokinetic modeling of FTY720 (2-amino-2[2-(-4-octylphenyl)ethyl]propane-1,3-diol hydrochloride) in rats after oral and intravenous doses

The preservationist paradox: modernism, environmentalism and the politics of spatial division

Setting the next agenda? British and French approaches to the second pillar of the Common Agricultural Policy

On the Prediction of the Human Response: A Recycled Mechanistic Pharmacokinetic/Pharmacodynamic Approach

Household debt, housing prices and resilience

Enacting Rural Sociology: Or what are the Creativity Claims of the Engaged Sciences?

Multicentre study of the clinical relevance of screening IVF patients for carrier status of the annexin A5 M2 haplotype

Suchergebnisse filtern